Black Rock Inc. Athira Pharma, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 676,244 shares of ATHA stock, worth $493,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares

676,244

Previous 667,278 1.34%

Holding current value

$493,658

Previous $1.83 Million 1.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.92 - $2.71 $17,214 - $24,297	8,966 Added 1.34%	676,244 $1.79 Million
Q1 2024 May 10, 2024	BUY	$2.24 - $4.15 $10,339 - $19,156	4,616 Added 0.7%	667,278 $1.83 Million
Q4 2023 Feb 13, 2024	BUY	$1.39 - $2.46 $241 - $428	174 Added 0.03%	662,662 $1.61 Million
Q3 2023 Nov 13, 2023	SELL	$1.9 - $3.16 $13,832 - $23,004	-7,280 Reduced 1.09%	662,488 $1.34 Million
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $3.78 Million - $5.75 Million	-1,601,690 Reduced 70.51%	669,768 $1.98 Million
Q1 2023 May 12, 2023	SELL	$2.26 - $4.22 $207,384 - $387,239	-91,763 Reduced 3.88%	2,271,458 $5.68 Million
Q4 2022 Feb 13, 2023	SELL	$2.76 - $3.71 $628,915 - $845,390	-227,868 Reduced 8.79%	2,363,221 $7.49 Million
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $311,479 - $420,975	106,307 Added 4.28%	2,591,089 $7.7 Million
Q2 2022 Aug 12, 2022	BUY	$2.74 - $13.43 $190,923 - $935,802	69,680 Added 2.89%	2,484,782 $7.58 Million
Q1 2022 May 12, 2022	SELL	$8.96 - $13.51 $363,614 - $548,262	-40,582 Reduced 1.65%	2,415,102 $32.6 Million
Q4 2021 Feb 10, 2022	BUY	$9.17 - $16.39 $4.1 Million - $7.32 Million	446,781 Added 22.24%	2,455,684 $32 Million
Q3 2021 Nov 09, 2021	BUY	$9.15 - $11.09 $145,073 - $175,831	15,855 Added 0.8%	2,008,903 $18.8 Million
Q2 2021 Aug 11, 2021	BUY	$10.24 - $20.87 $20.4 Million - $41.6 Million	1,993,048 New	1,993,048 $20.4 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

112K

Put Options Held

68K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $27.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account